| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 213.94B | 208.37B | 198.55B | 177.83B | 133.00B | 112.11B |
| Gross Profit | 22.16B | 21.41B | 23.30B | 19.70B | 14.41B | 13.36B |
| EBITDA | 15.71B | 14.34B | 16.79B | 13.87B | 10.37B | 9.65B |
| Net Income | 8.06B | 7.28B | 9.12B | 7.78B | 6.13B | 5.54B |
Balance Sheet | ||||||
| Total Assets | 143.99B | 138.44B | 134.59B | 112.03B | 85.91B | 73.19B |
| Cash, Cash Equivalents and Short-Term Investments | 42.40B | 41.40B | 46.16B | 32.85B | 29.68B | 26.49B |
| Total Debt | 44.38B | 43.85B | 41.79B | 42.45B | 31.86B | 27.50B |
| Total Liabilities | 82.01B | 78.00B | 77.05B | 73.86B | 56.17B | 47.48B |
| Stockholders Equity | 59.30B | 57.78B | 55.12B | 35.92B | 28.95B | 25.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 185.00M | 5.75B | 2.58B | 5.25B | 4.79B |
| Operating Cash Flow | 0.00 | 8.90B | 10.80B | 11.41B | 6.09B | 7.97B |
| Investing Cash Flow | 0.00 | -10.61B | -5.86B | -14.02B | -5.24B | -4.58B |
| Financing Cash Flow | 0.00 | -3.04B | 8.58B | 5.53B | 799.00M | 14.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥160.60B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
67 Neutral | ¥310.83B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥326.21B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
66 Neutral | ¥171.78B | 12.74 | ― | 1.84% | 10.32% | 42.14% | |
64 Neutral | ¥122.06B | 12.89 | ― | 3.21% | 8.14% | 11.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥327.21B | 20.24 | ― | 1.28% | 8.11% | -9.27% |